Results of the Prospective Multicenter Trial of Robotically Assisted Totally Endoscopic Coronary Artery Bypass Grafting

Robotic TECAB was accomplished with no mortality, low morbidity, and angiographic patency and reintervention rates comparable with published data. Although the use of CPB was a limitation of the technique, this experience represents a step toward more advanced procedures, such as multivessel or off-pump TECAB.